Blum RH - Search Results

1

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, Smith TJ, Rao U, Steele M, Blum RH. Kirkwood JM, et al. Among authors: blum rh. J Clin Oncol. 2000 Jun;18(12):2444-58. doi: 10.1200/JCO.2000.18.12.2444. J Clin Oncol. 2000. PMID: 10856105 Clinical Trial.

2

Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.

Kirkwood JM, Richards T, Zarour HM, Sosman J, Ernstoff M, Whiteside TL, Ibrahim J, Blum R, Wieand S, Mascari R. Kirkwood JM, et al. Cancer. 2002 Sep 1;95(5):1101-12. doi: 10.1002/cncr.10775. Cancer. 2002. PMID: 12209697 Free article. Clinical Trial.

3

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Kirkwood JM, et al. Among authors: blum rh. J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Corrected and republished. Clinical Trial.

4

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.

Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH. Falkson CI, et al. Among authors: blum rh. J Clin Oncol. 1998 May;16(5):1743-51. doi: 10.1200/JCO.1998.16.5.1743. J Clin Oncol. 1998. PMID: 9586887 Clinical Trial.

5

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586).

Tester WJ, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH. Tester WJ, et al. Among authors: blum rh. Lung Cancer. 1999 Sep;25(3):199-206. doi: 10.1016/s0169-5002(99)00054-9. Lung Cancer. 1999. PMID: 10512131 Clinical Trial.

6

Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.

Nishihori T, Abdo-Matkiwsky M, Fleishman SB, Blum RH. Nishihori T, et al. Among authors: blum rh. Am J Clin Oncol. 2005 Oct;28(5):526. doi: 10.1097/01.coc.0000145982.86749.b4. Am J Clin Oncol. 2005. PMID: 16199995

7

Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group.

Giantonio BJ, Hochster H, Blum R, Wiernik PH, Hudes GR, Kirkwood J, Trump D, Oken MM. Giantonio BJ, et al. Invest New Drugs. 2001;19(1):89-92. doi: 10.1023/a:1006458232384. Invest New Drugs. 2001. PMID: 11291838 Clinical Trial.

8

Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).

Chang AY, Tu ZN, Smith JL, Bonomi P, Smith TJ, Wiernik PH, Blum R. Chang AY, et al. Invest New Drugs. 1995;13(2):137-41. doi: 10.1007/BF00872862. Invest New Drugs. 1995. PMID: 8617576 Clinical Trial.

9

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.

Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R. Loehrer PJ Sr, et al. J Clin Oncol. 1994 Jun;12(6):1164-8. doi: 10.1200/JCO.1994.12.6.1164. J Clin Oncol. 1994. PMID: 8201378 Clinical Trial.

10

Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD, Eisenberg B; Radiation Therapy Oncology Group Trial 9514. Kraybill WG, et al. Among authors: blum rh. J Clin Oncol. 2006 Feb 1;24(4):619-25. doi: 10.1200/JCO.2005.02.5577. J Clin Oncol. 2006. PMID: 16446334 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page